Clinical Trial

Procalcitonin as a Marker of Severity of Non-cystic Fibrosis Bronchiectasis in Children

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated April 17, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to evaluate the role of procalcitonin in bronchoalveolar lavage as a biomarker for assessment of severity of non-CF bronchiectasis in children in correlation with other markers (functional and radiological severity )
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT06352944
Lead Sponsor Assiut University
Conditions Non-cystic Fibrosis Bronchiectasis
Enrollment 30 participants
Start Date 2024-07
Primary Completion 2025-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-04-17